| Literature DB >> 30691710 |
Amira Ali Ramadan1, Jonathan M Gaffin2, Elliot Israel3, Wanda Phipatanakul4.
Abstract
Corticosteroids are the most effective treatment for asthma; inhaled corticosteroids (ICSs) are the first-line treatment for children and adults with persistent symptoms. ICSs are associated with significant improvements in lung function. The anti-inflammatory effects of corticosteroids are mediated by both genomic and nongenomic factors. Variation in the response to corticosteroids has been observed. Patient characteristics, biomarkers, and genetic features may be used to predict response to ICSs. The existence of multiple mechanisms underlying glucocorticoid insensitivity raises the possibility that this might indeed reflect different diseases with a common phenotype.Entities:
Keywords: Adult asthma; Childhood asthma; Corticosteroid resistance; Corticosteroid response; Inhaled corticosteroids
Mesh:
Substances:
Year: 2019 PMID: 30691710 PMCID: PMC6355159 DOI: 10.1016/j.ccm.2018.10.010
Source DB: PubMed Journal: Clin Chest Med ISSN: 0272-5231 Impact factor: 2.878